Cisplatin treatment of testicular cancer introduces long-term changes to the epigenome

被引：0
|
作者：
Rounge, Trine B. [1 ]
Bucher-Johannessen, Cecilie [1 ]
Page, Christian M. [2 ]
Haugen, Trine B. [3 ]
Fossa, Sophie D. [2 ]
Haugnes, Hege S. [4 ]
Grotmol, Tom [1 ]
机构：
[1] Canc Registry Norway, Oslo, Norway
[2] Oslo Univ Hosp, Oslo, Norway
[3] Oslo & Akershus Univ Coll Appl Sci, Oslo, Norway
[4] Univ Hosp North Norway, Tromso, Norway
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-4325
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4325
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Cisplatin treatment of testicular cancer patients introduces long-term changes in the epigenome
    Cecilie Bucher-Johannessen
    Christian M. Page
    Trine B. Haugen
    Marcin W. Wojewodzic
    Sophie D. Fosså
    Tom Grotmol
    Hege S. Haugnes
    Trine B. Rounge
    Clinical Epigenetics, 2019, 11
  • [2] Cisplatin treatment of testicular cancer patients introduces long-term changes in the epigenome
    Bucher-Johannessen, Cecilie
    Page, Christian M.
    Haugen, Trine B.
    Wojewodzic, Marcin W.
    Fossa, Sophie D.
    Grotmol, Tom
    Haugnes, Hege S.
    Rounge, Trine B.
    CLINICAL EPIGENETICS, 2019, 11 (01)
  • [3] Long-term Morbidity of Testicular Cancer Treatment
    Fung, Chunkit
    Fossa, Sophie D.
    Williams, Annalynn
    Travis, Lois B.
    UROLOGIC CLINICS OF NORTH AMERICA, 2015, 42 (03) : 393 - +
  • [4] Long-term complications of testicular cancer treatment
    Witjes, J. A.
    Van Der Schans, S.
    Spermon, R.
    Kiemeney, L. A.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 157 - 157
  • [5] Continuing increased risk of second cancer in long-term testicular cancer survivors after treatment in the cisplatin era
    Hellesnes, Ragnhild
    Kvammen, Oivind
    Myklebust, Tor A.
    Bremnes, Roy M.
    Karlsdottir, Asa
    Negaard, Helene F. S.
    Tandstad, Torgrim
    Wilsgaard, Tom
    Fossa, Sophie D.
    Haugnes, Hege S.
    INTERNATIONAL JOURNAL OF CANCER, 2020, 147 (01) : 21 - 32
  • [6] TREATMENT OF HIGH-RISK, NONSEMINOMATOUS TESTICULAR CANCER WITH CISPLATIN, IFOSFAMIDE AND BLEOMYCIN - LONG-TERM RESULTS
    WANDL, UB
    GUNZEL, K
    KATH, R
    SCHEULEN, ME
    HAYUNGS, J
    HOFFKEN, K
    SEEBER, S
    NIEDERLE, N
    ANNALS OF ONCOLOGY, 1992, 3 (02) : 123 - 126
  • [7] The lack of a long-term effect of cisplatin based combination chemotherapy on serum cholesterol for the treatment of testicular cancer
    Fenton, DW
    Verma, S
    Venner, P
    Sawhney, R
    Mackey, JR
    JOURNAL OF UROLOGY, 2002, 168 (05): : 1971 - 1974
  • [8] Long-term changes in testosterone levels in testicular cancer survivors
    Bandak, M.
    Jorgensen, N.
    Juul, A.
    Lauritsen, J.
    Mortensen, M. S.
    Kier, M. G. G.
    Daugaard, G.
    ANNALS OF ONCOLOGY, 2016, 27
  • [9] Long-term serum platinum changes and their association with cisplatin-related late effects in testicular cancer survivors
    Hjelle, Line V.
    Gundersen, Per O. M.
    Hellesnes, Ragnhild
    Sprauten, Mette
    Brydoy, Marianne
    Tandstad, Torgrim
    Wilsgaard, Tom
    Fossa, Sophie D.
    Oldenburg, Jan
    Bremnes, Roy M.
    Haugnes, Hege S.
    ACTA ONCOLOGICA, 2018, 57 (10) : 1392 - 1400
  • [10] Cardiovascular disease as a long-term complication of treatment for testicular cancer
    Huddart, RA
    Norman, A
    Shahidi, M
    Horwich, A
    Coward, D
    Nicholls, J
    Dearnaley, DP
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (08) : 1513 - 1523
12345